Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Positron emission tomography and epilepsy.

Rey Casse1, Christopher C Rowe, Mark Newton

  • 1Department of Nuclear Medicine and Center for PET, University of Melbourne, Austin & Repatriation Medical Center, Heidelberg, Victoria, Australia.

Molecular Imaging and Biology
|October 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator.

Clinical and translational radiation oncology·2026
Same author

A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Identifying factors associated with sleep disturbance among adults seeking outpatient psychiatric services for anxiety and related disorders.

Bulletin of the Menninger Clinic·2026
Same author

Cancer workforce-a global crisis: a Lancet Oncology Commission.

The Lancet. Oncology·2026
Same author

Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers.

The Lancet. Oncology·2026
Same author

Estimating global cancer survival and mortality from 1990 to 2050: a simulation-based analysis of 17 cancers.

The Lancet. Oncology·2026

Positron emission tomography (PET) is crucial for evaluating epilepsy, especially for seizure focus localization in intractable partial epilepsy. FDG-PET accurately identifies hypometabolism, aiding surgical treatment decisions and predicting outcomes.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Nuclear Medicine

Background:

  • Epilepsy management often requires precise localization of the epileptogenic zone.
  • Surgical intervention is a key treatment option for intractable partial epilepsy.
  • Advanced imaging techniques are vital for accurate diagnosis and treatment planning.

Purpose of the Study:

  • To review the current applications of Positron Emission Tomography (PET) in epilepsy diagnosis and management.
  • To assess the accuracy of PET in localizing seizure foci compared to Magnetic Resonance Imaging (MRI).
  • To evaluate the prognostic value of PET findings for epilepsy surgery outcomes.

Main Methods:

  • A comprehensive literature review was conducted using MEDLINE and other databases.

Related Experiment Videos

  • Publications since 1994 were analyzed for PET and MRI accuracy in seizure focus localization.
  • Individual patient data were tabulated to determine seizure focus localization rates and surgical outcome prediction.

    • Main Results:

    • 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-PET typically shows hypometabolism at epileptogenic sites.
    • In intractable temporal lobe epilepsy (TLE), FDG-PET detected unilateral temporal lobe hypometabolism (UTH) in 86% of patients, compared to 76% with MRI abnormalities.
    • Ipsilateral UTH predicted good surgical outcomes in 86% of TLE patients, and 82% when MRI was normal. 11C-Flumazenil shows promise for more restricted abnormality detection.

    Conclusions:

    • FDG-PET plays a significant role in evaluating patients with intractable partial epilepsy, especially when surgery is considered.
    • PET imaging aids in understanding epilepsy pathophysiology and guiding treatment strategies.
    • Further development of specific PET tracers may enhance its clinical utility in epilepsy management.